Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma

doi:10.1158/1538-7445.AM2020-2207

	Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma
	He, Xi-Ran 1; Du, Yang2 ; Jin, Yu-Shen2 ; Bai, Hua 1; Tian, Jie 2; Wang, Jie 1
发表期刊	CANCER RESEARCH
ISSN	0008-5472
	2020-08-01
卷号	80 期号:16 页码:2
DOI	10.1158/1538-7445.AM2020-2207
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000590059304235
出版者	AMER ASSOC CANCER RESEARCH
引用统计
文献类型	期刊论文
条目标识符	http://ir.ia.ac.cn/handle/173211/43184
专题	中国科学院分子影像重点实验室
作者单位	1.Canc Hosp, Natl Canc Ctr, Beijing, Peoples R China 2.Inst Automat, State Key Lab Management & Control Complex Syst, Beijing, Peoples R China
推荐引用方式 GB/T 7714	He, Xi-Ran,Du, Yang,Jin, Yu-Shen,et al. Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma[J]. CANCER RESEARCH,2020,80(16):2.
APA	He, Xi-Ran,Du, Yang,Jin, Yu-Shen,Bai, Hua,Tian, Jie,&Wang, Jie.(2020).Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma.CANCER RESEARCH,80(16),2.
MLA	He, Xi-Ran,et al."Upfront metronomic chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma".CANCER RESEARCH 80.16(2020):2.